We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
4brx
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ==Focal Adhesion Kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor== | |
| - | + | <StructureSection load='4brx' size='340' side='right' caption='[[4brx]], [[Resolution|resolution]] 2.05Å' scene=''> | |
| - | + | == Structural highlights == | |
| + | <table><tr><td colspan='2'>[[4brx]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BRX OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4BRX FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=KGW:2-(4-(2-METHOXY-4-MORPHOLINOPHENYLAMINO)-1,3,5-TRIAZIN-2-YLAMINO)-N-METHYLBENZAMIDE'>KGW</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_protein-tyrosine_kinase Non-specific protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.2 2.7.10.2] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4brx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4brx OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4brx RCSB], [http://www.ebi.ac.uk/pdbsum/4brx PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | We report herein the synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK (focal adhesion kinase) inhibitors and the evaluation of their anti-angiogenic activity on HUVEC cells. Generally, the effects of these compounds on endothelial cells could be correlated with their kinase inhibitory activity. The most efficient compounds displayed inhibition of viability against HUVEC cells in the micromolar range, as observed with TAE-226, which was designed by Novartis Pharma AG. X-ray crystallographic analysis of the co-crystal structure for compound 34 revealed that the mode of interaction with the FAK kinase domain is highly similar to that observed in the complex of TAE-226. | ||
| - | + | Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity.,Dao P, Jarray R, Le Coq J, Lietha D, Loukaci A, Lepelletier Y, Hadj-Slimane R, Garbay C, Raynaud F, Chen H Bioorg Med Chem Lett. 2013 Jun 24. pii: S0960-894X(13)00759-2. doi:, 10.1016/j.bmcl.2013.06.038. PMID:23845217<ref>PMID:23845217</ref> | |
| - | + | ||
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | == | + | ==See Also== |
| - | + | *[[Focal adhesion kinase|Focal adhesion kinase]] | |
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
[[Category: Gallus gallus]] | [[Category: Gallus gallus]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
| - | [[Category: Coq, J Le | + | [[Category: Coq, J Le]] |
| - | [[Category: Lietha, D | + | [[Category: Lietha, D]] |
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Integrin signaling]] | [[Category: Integrin signaling]] | ||
[[Category: Kinase inhibitor]] | [[Category: Kinase inhibitor]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Revision as of 09:52, 21 December 2014
Focal Adhesion Kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor
| |||||||||||
